Korro Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	169.71	36.94	81.33	222.16	200.26	42.19	17.94
Short-Term Investments	0	18.92	51.07	0	17.2	0	0
Cash & Cash Equivalents	169.71	55.85	132.41	222.16	217.46	42.19	17.94
Cash Growth	203.87%	-57.82%	-40.40%	2.16%	415.43%	135.21%	-
Other Current Assets	3.02	1.23	2.34	2.9	3.9	0.75	0.02
Total Current Assets	172.73	57.08	134.75	225.06	221.36	42.94	17.96
Property, Plant & Equipment	42.82	11.89	36.87	37.84	1.76	1.51	1.73
Long-Term Investments	3.41	4.54	11.72	0	0	0	0
Other Long-Term Assets	2.71	0.23	2.02	1.82	0.1	0.1	0.1
Total Long-Term Assets	48.94	16.66	50.61	39.66	1.86	1.61	1.83
Total Assets	221.66	73.74	185.36	264.72	223.22	44.55	19.79
Accounts Payable	7.28	2.61	2.75	5.51	1.22	1.86	0.99
Deferred Revenue	0	0	0	14.07	51.05	0	0
Current Debt	1.99	2.92	2.58	0.4	0	0	0
Other Current Liabilities	10.21	3.18	6.1	6.66	0.51	1.91	1.23
Total Current Liabilities	19.48	8.7	11.43	26.63	52.78	3.77	2.23
Long-Term Debt	31.22	0.21	43.02	45.6	0	0	0
Other Long-Term Liabilities	1.05	0	0.09	0	3.08	0.35	0.51
Total Long-Term Liabilities	32.27	0.21	43.11	45.6	3.08	0.35	0.51
Total Liabilities	51.75	8.91	54.53	72.23	55.86	4.12	2.74
Total Debt	33.21	3.13	45.6	45.99	0	0	0
Debt Growth	960.93%	-93.14%	-0.86%	-	-	-	-
Retained Earnings	-183.01	-101.83	-180.09	-95.4	-68.89	-49.09	-29.92
Comprehensive Income	0	-0.01	-0.06	0.03	0.05	0	0
Shareholders' Equity	169.91	-99.03	130.82	192.49	167.36	-52.06	-29.64
Net Cash / Debt	136.51	52.72	86.81	176.17	217.46	42.19	17.94
Net Cash / Debt Growth	158.92%	-39.27%	-50.72%	-18.99%	415.43%	135.21%	-
Net Cash Per Share	89.26	206.61	126.35	273.10	1257.08	1378.55	1275.93
Working Capital	153.25	48.38	123.32	198.43	168.58	39.16	15.73
Book Value Per Share	111.10	-388.09	190.42	298.41	967.47	-1700.90	-2108.50

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).